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Nanotechnology has emerged at the forefront of science research and technology development.
Carbon nanotubes (CNTs) are major building blocks of this new technology. They possess
unique electrical, mechanical, and thermal properties, with potential wide applications in the
electronics, computer, aerospace, and other industries. CNTs exist in two forms, single-wall
(SWCNTs) and multi-wall (MWCNTs). They are manufactured predominately by electrical
arc discharge, laser ablation and chemical vapor deposition processes; these processes involve
thermally stripping carbon atoms off from carbon-bearing compounds. SWCNT formation
requires catalytic metals. There has been a great concern that if CNTs, which are very light,
enter the working environment as suspended particulate matter (PM) of respirable sizes, they
could pose an occupational inhalation exposure hazard. Very recently, MWCNTs and other
carbonaceous nanoparticles in fine (<2.5 µm) PM aggregates have been found in combustion
streams of methane, propane, and natural-gas flames of typical stoves; indoor and outdoor fine
PM samples were reported to contain significant fractions of MWCNTs. Here we review sev-
eral rodent studies in which test dusts were administered intratracheally or intrapharyngeally
to assess the pulmonary toxicity of manufactured CNTs, and a few in vitro studies to assess
biomarkers of toxicity released in CNT-treated skin cell cultures. The results of the rodent stud-
ies collectively showed that regardless of the process by which CNTs were synthesized and the
types and amounts ofmetals they contained, CNTswere capable of producing inflammation, ep-
ithelioid granulomas (microscopic nodules), fibrosis, and biochemical/toxicological changes in
the lungs. Comparative toxicity studies in which mice were given equal weights of test materials
showed that SWCNTs were more toxic than quartz, which is considered a serious occupational
health hazard if it is chronically inhaled; ultrafine carbon black was shown to produce mini-
mal lung responses. The differences in opinions of the investigators about the potential hazards
of exposures to CNTs are discussed here. Presented here are also the possible mechanisms of
CNT pathogenesis in the lung and the impact of residual metals and other impurities on the
toxicological manifestations. The toxicological hazard assessment of potential human exposures
to airborne CNTs and occupational exposure limits for these novel compounds are discussed
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in detail. Environmental fine PM is known to form mainly from combustion of fuels, and has
been reported to be a major contributor to the induction of cardiopulmonary diseases by pol-
lutants. Given that manufactured SWCNTs and MWCNTs were found to elicit pathological
changes in the lungs, and SWCNTs (administered to the lungs of mice) were further shown to
produce respiratory function impairments, retard bacterial clearance after bacterial inocula-
tion, damage the mitochondrial DNA in aorta, increase the percent of aortic plaque, and induce
atherosclerotic lesions in the brachiocephalic artery of the heart, it is speculated that exposure to
combustion-generated MWCNTs in fine PMmay play a significant role in air pollution-related
cardiopulmonary diseases. Therefore, CNTs frommanufactured and combustion sources in the
environment could have adverse effects on human health.
Keywords Cardiopulmonary Diseases, Fibrosis, Fullerenes, Granulomas, Intratracheal Instilla-
tion, Multi-Wall Carbon Nanotubes, Nanomaterials, Nanotechnology, Natural Gas
Combustion, ParticulateMatter, PM2.5, Pulmonary Toxicity, Risk Assessment, Single-
Wall Carbon Nanotubes
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I. INTRODUCTION
A. Nanotechnology and Carbon Nanotubes
The rapid growth in research and development involving ma-
terials of nanoscale size has propelled nanotechnology to the
forefront of science and technology development. The antic-
ipation that nanotechnology would become the strategic and
dominating science and engineering field of the 21st century
prompted the U.S. President and the National Science and Tech-
nology Council to promote nanotechnology and to predict that
it would lead the United States to the next industrial revolu-
tion (National Science and Technology Council, 2003; White
House Press Secretary, 2000). Of the materials associated with
the inception and progression of nanotechnology, fullerenes and
carbon nanotubes (CNTs) are the two most important and noted
ones. It is the potential applications of these two nanomaterials,
especially CNTs, that helped trigger the rush to nanotechnology
research and development.
In 1985, the discovery of C60 molecules by Harold Kroto,
James Heath, Sean O’Brien, Robert Curl, and Richard Smalley
(Kroto et al., 1985) opened a whole new frontier in the chem-
istry of carbon. C60 is a spherical molecule with carbon atoms
arranged in a pattern like that of a geodesic dome; the molecule
was given the name “buckminsterfullerene.” Since the discov-
ery of C60, fullerenes of larger size, as well as derivatives
of C60 fullerene, have been synthesized and intensively in-
vestigated (Kroto and Walton, 1993; McKeith, 2002). These
cagelike nanostructures and other related molecules have been
projected to have wide industrial and medical applications.
For the discovery of fullerenes, Curl, Kroto, and Smalley
were awarded the Nobel Prize in Chemistry in 1996 (Kungl.
Vetenskapsakademien [Royal Swedish Academy of Sciences],
1996).
B. Manufactured Carbon Nanotubes
1. Discovery of Carbon Nanotubes
In a graphite arc process that formed fullerenes from atom-
ized carbon, Sumio Iijima in 1991 discovered multiwall CNTs
(MWCNTs, Figure 1) deposited at the graphite anode (Iijima,
1991, 2004). Shortly after, Iijima succeeded in synthesizing
single-wall CNTs (SWCNTs) (Figure 1) in the presence ofmetal
catalyst and found that the yield of SWCNTs could be increased
by increasing the amount of cobalt or other catalytic transition
metals (Iijima and Ichihashi, 1993). Adapting the laser ablation
process that was used to make fullerenes, Richard Smalley’s
group at Rice University (Houston, TX) succeeded in synthe-
sizing SWCNTs with a much higher yield and greater purity
than the arc process produced (Arepalli et al., 2004a; Guo et al.,
1995; Thess et al., 1996). Compared with SWCNTs, MWCNTs
are more heterogeneous and difficult to characterize and study.
Theoretical calculations and results of experiments on SWCNTs
show that SWCNTs have highly desirable mechanical, thermal,
photochemical, and electrical properties (Wikipedia, 2005).
Seeing great potential applications of the two closely re-
lated families (fullerenes and CNTs) of nanomaterials and other
manufactured nanomaterials, more than a dozen government
agencies under the leadership of the National Science and Tech-
nologyCouncil (2003) jointly established the InteragencyWork-
ing Group on Nanotechnology, shortly after the awarding of the
Nobel Prize for fullerene research. In 2000, this federal effort
was raised by President Clinton to the level of a federal initia-
tive,whichwasknownas theNationalNanotechnology Initiative
(NNI) (White House Press Secretary, 2000). One of the major
objectives of the NNI is “developing materials that are 10 times
stronger than steel, but a fraction of the weight for making all
kinds of land, sea, air and space vehicles lighter and more fuel
efficient.” The materials implicated in the initiative are CNTs.
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FIG. 1. (A) to (D): SWCNTs; (E) to (H):MWCNTs. Scanning electronmicroscope (SEM) images showSWCNT (B) andMWCNT
(F) aggregates; transmission electron microscope (TEM) images show raw SWCNT bundles (ropes) with metal nanoparticles (C),
and individual multiwall tubes (G). High-resolution TEM images show a cross-section of a SWCNT bundle (D) consisting of>25
tubes and some amorphous carbon on the edges, and a longitudinal cross-section of a MWCNT (H) with an empty central cavity
and ∼20 walls on each side and some amorphous carbon. (C), (G), and (H) are courtesy of P. Nikolaev of the JSC Nanomaterials
Group, and (F) is courtesy of J. Rodriguez of Universitat de Barcelona, Spain.
2. Potential Wide Applications of Carbon Nanotubes
CNTs are light in weight and have the strongest tensile
strength of any synthetic fiber. According to Smalley (1999),
“They are expected to produce fibers 100 times stronger than
steel at only 1/6th the weight—almost certainly the strongest
fibers that will ever be made out of anything.” Even compos-
ite materials containing CNTs may have incredible strength,
potentially sufficient to allow the building of such things as
spacecraft structures, space elevators, artificial muscles, com-
bat jackets, and land and sea vehicles (Dresselhaus et al., 2000;
Files, 2000; Wikipedia, 2005; Yowell et al., 2002).
In addition to their strength and light weight, some forms
of CNTs can conduct electricity better than copper (Smalley,
1999). To harness these properties, the National Aeronautics
and Space Administration (NASA) just awarded an $11-million
contract to the Carbon Nanotechnology Laboratory of Rice Uni-
versity to produce a prototype power cablemade of CNTs (John-
son Space Center, 2005). Smalley remarked that, in addition to
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their applications in space exploration,CNTcableswill someday
“rewire the world, replacing aluminum and copper in virtually
every application and permitting a vast increase in the capac-
ity of the nation’s electrical grid” (Boyd, 2005). Because CNTs
can have conducting or semiconducting properties, depending
on their nanostructures, the CNT nanofibers would have po-
tential applications in the electronics and computer industries.
These highly desirable electrical properties may allow CNT
nanostructures to be formed by joining nanotubes of two dif-
ferent diameters end to end to form a diode, suggesting the pos-
sibility of constructing electronic computer circuits entirely out
of nanotubes (Wikipedia, 2005). According to Smalley (1999),
“Several decades fromnowwemay see our current silicon-based
microelectronics supplanted by a carbon-based nanoelectronics
of vastly greater power and scope.” Nanotubes have been shown
to be superconducting at low temperature. They also have un-
usual thermal and optical properties. As Ajayan et al. (1999)
have stated, “It is rare to come across a material that has such a
range of remarkable properties.”
3. Synthesis of Carbon Nanotubes and Impurities in Synthetic
Products
Commercially, CNTs are produced from carbon atoms or
clusters vaporized from graphite by arc discharge or by pulsed
laser vaporization (Ando et al., 2004), or by a chemical-vapor
deposition (CVD) process in which thermally and catalytically
generated carbon atoms from hydrocarbon gaseous precursors
are converted to solid structured materials (Leonhardt, 2004).
Nikolaev in Smalley’s laboratory developed a gas-phase cat-
alytic growth of SWCNTs from carbon atoms generated from
a continuous high-pressure stream of carbon monoxide (Niko-
laev et al., 1999). This patented syntheticmethod is a variation of
CVD and is referred to by Smalley’s group as the HiPco process.
All of these synthetic processes involve thermal vaporization
of carbon and metal catalysts. Carbon sources are graphite, or
gaseous carbon-bearing compounds such as CO, methane, ethy-
lene, or other hydrocarbons. The vaporized carbon atoms (or
clusters) and hot metal catalysts co-condense into gas-phase
molten nanoparticles where nanotubes grow (Moisala et al.,
2003; Scott et al., 2001). MWCNTs can be produced without
metals; however, the presence of a small amount of metal cat-
alyst helps to align the nanotubes. An increase in the metal
nanoparticles-to-carbon ratio favors the formation of SWCNTs
(Iijima and Ichihashi, 1993). Synthesis of CNTs is generally car-
ried out in an inert atmospherewithin a temperature range of 600
to 1200◦C. At the temperature of CNT synthesis, the metal(s)
needs to be catalytically active and remain in the molten state,
allowing dissolution of carbon atoms in the metal(s); of the met-
als that meet these requirements, those most commonly used are
iron, nickel, cobalt, and molybdenum (Wikipedia, 2005). All of
the SWCNT and MWCNT products produced by these meth-
ods contain residual metals (Arepalli et al., 2004b). Depending
on the manufacturing process, an unprocessed SWCNT product
may contain up to 50% of metal by weight; the metal content in
a MWCNT product is much less. The metal impurities are gen-
erally undesirable; some commercial products (Figure 2) are
sold in purified forms after the removal of metals (Figure 3).
CNT products also contain non-NT carbon impurities, such as
soot, fullerene, and graphite; the amount and type of impuri-
ties depend on the synthetic methods and manufacturers. Raw
and purified SWCNT products currently sold by SES (Houston,
TX) contain nanotubes at only 20–40% and≤75%, respectively
(SES Research, 1999). The HiPco process of Rice University
produces CNTs with very little non-nanotube carbon (Figure
3A); a test result of a purified HiPco CNT sample (Figure 3B)
showed that >99% of the carbon content was in nanotube mor-
phology and iron accounted for 0.23% of the sample weight
(Shvedova et al., 2005).
4. Physical Characteristics, Properties, and Appearance
of Carbon Nanotube Products
A SWCNT is a nanosize tube or fiber formed by bonded car-
bon atoms arranged in a hexagonal pattern; the tube is generally
capped at one end (Figure 1A). Structurally, it resembles a rolled-
up single layer of graphene or graphite sheet. Both SWCNTs and
C60 fullerene have diameters of about 1 nanometer (∼1/50,000
of a human hair). Fullerene has a soccer ball-like structure while
a SWCNT appears like a single layer of rolled-up chicken wire.
An individual SWCNT is a very thin fiber at least several mi-
crometers long, with an aspect ratio (length/diameter) greater
than 1000 (Ajayan and Ebbesen, 1997). MWCNTs have two
or more concentric layers with various diameters and lengths
(Figures 1G and 1H). Since the time CNTs were discovered,
enormous research efforts have been devoted to making these
fibrous materials longer.
SWCNTs do not naturally exist as individual tubes; van der
Waals forces between themolecules cause them to aggregate into
microscopic bundles or ropes, which in turn agglomerate loosely
into small clumps. For example, SWCNT products made by the
laser ablation process at the NASA Johnson Space Center (JSC)
nanotechnology laboratory consist of aggregates of tiny ropes
(Figure 1B). Each is generally formed by bundling 20 to 50 tubes
(with a collective diameter of ∼20 nm, Figure 1D) into a fiber
several thousand nanometers long (Arepalli et al., 2004a). The
ropes then aggregate (Figure 1B) into loose clumps or flakes;
this unprocessed ash-like material (Figure 2A), if undisturbed,
contains very little fine dust. The appearance of the bulk ma-
terial depends on the processes by which it was synthesized or
manufactured. Currently, SWCNTs made by the HiPco or laser
process have fewest wall defects. Defects (like kinks in a straw)
can diminish the effectiveness of the attraction force and sub-
sequently reduce the formation of parallel bundles and ropes.
In comparison, the arc-discharge SWCNT product (Figure 2B)
made by CarboLex Inc. (Lexington, KY) and sold by Aldrich
Chemical Company Inc. (Milwaukee, WI) looks like a black
powder, similar to a carbon-black toner. The raw CNTs made by
Rice’s HiPco process are loose black clumps (Figures 2D and
2F). This unprocessed HiPco product, although it contains 30%
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FIG. 2. (A) A sample of SWCNTs produced by the pulsed laser-vaporization process at NASA JSC Nanotube Arc Discharge
Facility; this product contains very few fine particles. (B) SWCNTs produced by CarboLex’s electric-arc process; the product
is a fine powder. (C) MWCNTs produced by CarboLex electric arc; the product contains fine particles. (D) SWCNTs made by
the Rice HiPco process; the product contains fine particles. (E) SWCNTs made by the HiPco process, purified, and produced as
tiny pearl-like granules; the product contains essentially no fine particles. (F) The transfer of HiPco SWCNTs between containers
shows that the product is light-weight and easily becomes airborne. (Figure F is courtesy of A. Maynard of NIOSH; Baron et al.,
2003). A human hair is shown in some of the pictures for size comparison.
iron by weight, is very light (Figure 2F) and the bulk density is
very low (∼1mg/cm3) (Baron et al., 2003).MWCNTs also have
van der Waals forces (Yu et al., 2000), but they are less effective
than those of SWCNTs. Because of their weaker van der Waals
forces and structural heterogeneity, MWCNTs generally exist
in single tubes (like spaghetti) and form very few bundles. The
tubes or bundles look like microscopic ropes (Figures 1F and
1G). However, the appearance of bulk MWCNT product (Fig-
ure 2C) is similar to that of SWCNTs (Figure 2B) made by the
same company (CarboLex).
Because CNTs can be made by several methods and by dif-
ferent manufacturers who use different catalytic metals, car-
bon sources, and processing conditions (such as pressure and
temperature), the length of individual CNTs and the purity
of the raw products can vary, even from batch to batch (Cui
et al., 2000). In addition to the difference in synthetic processes,
differences in postmanufacture processing affect the physical
characteristics of a commercial CNT product. For example, the
commercial purified HiPco product of Carbon Nanotechnolo-
gies Incorporated (CNI, Houston, TX) is prepared and sold as
tiny pearl-like granules, which contain few or no fine particles
that would pose an inhalation risk (Figure 2E). Compression
of loose clumps into a powder or preparation of granules from
purified CNTs increases the compactness of the bulk products
for ease of handling and shipment and would also affect the
physical appearance of the CNT particles. Thus, the physical
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FIG. 3. TEM pictures on the top show the presence of impurities (carbon-coated metal nanoparticles, etc) in raw HiPco- and laser-
produced CNT samples. The bottom pictures show the samples after purification. Notice that the purified HiPco sample contains
essentially all carbon nanotubes; the purity of a final product depends on type of raw CNT product and extent of purification.
characteristics of aCNTproduct depend on its purity, themethod
by which it was synthesized, and postsynthetic processing. The
difference in physical characteristics of CNTs, which depend on
manufacturing processes, will affect the health risks of exposure
to the product. The knowledge of these processes is important
information for an industrial hygienist, toxicologist, or risk as-
sessor who is assessing the toxicological risk of workers being
exposed to a particular CNT product.
5. Potential Occupational Exposures to Manufactured
Carbon Nanotubes
At present, the production volume of CNTs is still small
and the products remain expensive. The price of SWCNTs was
hundreds of thousands of dollars per pound in 2003, accord-
ing to Richard Smalley (Bearden, 2003). Raw SWCNTs and
MWCNTs are sold currently byBuckyUSA (Houston) at>$100
per gram (or >$50,000/lb) (BuckyUSA, 2005). In 2003, Baron
et al. (2003) of the aerosol group of the National Institute of
Occupational Safety and Health (NIOSH) visited CNT synthe-
sis laboratories at Rice University and NASA’s Johnson Space
Center and the CNTmanufacturing facility at CarbonNanotech-
nologies, Inc. (CNI, Houston), where SWCNTs are produced
by the HiPco or laser processes. The laboratories were making
only several grams per day at that time (Shvedova et al., 2005).
These NIOSH scientists observed the recovery of CNTs from
synthetic ovens and reported that handling of the collected sam-
ples was gentle, and losses of this expensive material were min-
imized. As expected, they found very few CNTs in the working
environments of these facilities; the airborne concentrations of
CNTswere less than 53µg/m3 (Maynard et al., 2004). These fa-
cilities had implemented excellent industrial hygiene measures
(Figure 4).
However, Smalley predicted that hundreds or thousands of
tons ofCNTs could be produced in 5 to 10 years (Ball, 2001), and
“in time,millions of tonnes of nanotubeswill be producedworld-
wide every year” (Taubes, 2002). The Department of Energy’s
2010 target goal for the price of CNTs is $8/kg (or <$20/lb).
The extent of industrial and commercial applications would de-
pend on the price of CNT raw materials. If the CNT indus-
try achieved the goal of “a couple dollars a pound” (Bearden,
2003), then millions of tons of CNTs could be produced an-
nually. Such a large production volume would involve a very
large workforce, and many workers would likely be exposed to
these lightweight materials during CNT synthesis and postsyn-
thetic material collection, handling, purification, and packaging
(Figure 4). The purity of a CNT product and the manufacturing
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FIG. 4. Photograph showing skin could be contaminated with
very fine CNT dust if gloves were not worn. (Courtesy of A.
Maynard of NIOSH; Baron et al., 2003).
process and postsynthetic processing it undergoes determine its
physical characteristics (section I.B.4). These physical charac-
teristics will determine its ability to enter the environment. Thus,
the occupational risk of exposure of a worker will depend on
what product is being handled and at which phase.
CNTs are strong and light; these very desirable properties
would make CNTs very useful in newmaterial development and
structural engineering. Progress has been made in incorporating
CNTs into fabrics, plastic, rubbers, reinforced structures, com-
posite materials, and household commodities (Laxminarayana
and Jalili, 2005;Nanocyl, 2005; Smalley, 2000; Sreekumar et al.,
2004; Ward et al., 2005; Wikipedia, 2005). If CNT production
increases and prices drop, uses in these areas will be greatly
expanded. Occupational exposures to airborne CNT dust could
occur in the processes of making these products. During incor-
poration of CNTs into some of these types of materials, the CNT
raw materials (in such forms as the clumps shown in Figure 2A
FIG. 5. Size distribution of particles generated from a raw HiPco carbon nanotube sample using a single-component vortex-shaker
fluidized bed; data were smoothed for clarity by the original authors. (Courtesy of A. Maynard of NIOSH; Baron et al., 2003).
and the purified granules shown in Figure 2E) will need to be
pulverized and homogenized; working with pulverized CNTs,
or resins or mixtures containing fine CNT particles, would pose
a risk of inhalation exposure. It is important to note that some of
the factories would be dustier because they would probably not
have industrial hygiene standards of the same caliber as the first-
class facilities that were visited by the NIOSH aerosol group,
who found very little airborne CNT dust.
A study by the NIOSH aerosol group on a raw HiPco sample
and a laser-synthesized CNT sample produced by Rice Univer-
sity revealed that gentle agitation (blowing air over the mate-
rial shaken in a vortex) produced large airborne clumps (Baron
et al., 2003;Maynard et al., 2004). Very few small particleswere
present. At high agitation levels, more airborne NT particles
were generated; the particles were 10 µm or less, which are
mostly respirable sizes, with some being in the ultrafine range
(Figure 5) (Maynard et al., 2004). Thus, if CNTs are subjected
to vigorous mechanical processes (such as agitation, grinding,
and pulverizing), dust of respirable sizes will be produced, and
occupational inhalation exposures could occur. During manu-
facturing and handling, CNT particulate matter (PM) could also
land on the skin of workers if it is not protected (Figure 4).
6. Environmental Health Issues of Manufactured
Carbon Nanotubes
The synthesis of CNTs does not require organic solvents. It
is considered a “green” industrial process. Currently, it is ex-
pected that very little of these very expensive materials will find
its way to contaminate the outdoor environment as industrial
waste. However, if the price drops substantially and CNTs are
incorporated into industrial products and household commodi-
ties that are used world-wide, the general public could also be
exposed to low levels of CNTs. In the United States we have
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witnessed the use of asbestos in automotive brake shoes un-
til it was found that asbestos particles generated from abrasion
contribute to environmental pollution, and the U.S. Environ-
mental Protection Agency banned use of this carcinogenic ma-
terial in automobiles (Federal Register, 1989). CNTs are light
and strong, and if the price of CNTs drops to a few dollars a
pound, applications of CNTs will expand to automobiles and
other products that could be subject to deterioration. Wear and
tear on products containing CNTs could generate fine particu-
late matter that may contribute to environmental pollution. In-
cineration of discarded articles or wastes that contain CNTs
may release some CNTs into the environment. Before the use of
CNTs become more widespread, it is important that the chronic
toxicity of CNT particulate matter be studied and known, and
appropriate safeguards against environmental contamination be
implemented.
C. Multiwall Carbon Nanotubes Generated
by Fuel Combustion
As discussed in Section I.B.3, CNTs could be produced from
carbon atoms thermally generated from hydrocarbons (such as
methane and acetylene) (Kong et al., 1998; Ren et al., 1998).
The synthesis of CNTs is generally carried out with the addi-
tion of catalytic metals. In fact, it is known that the synthesis
of MWCNTs can occur without metal catalysts (Cumings and
Zettl, 2004; Nanotech Co. Ltd., 2003; Tomanek, 1999). MWC-
NTs were first reported to have been produced from carbon
thermally vaporized from graphite without the presence of a
metal (Iijima, 1991). Che et al. (1998) observed formation of
MWCNTs (diameters of about 20 nm) when ethylene/pyrene
was pyrolyzed at 545◦C in the presence of Ni; without cata-
lysts, MWCNT formation occurred at 900◦C. Many daily heat
production or energy-generating activities involve burning of
hydrocarbons at temperatures greater than 1000◦C. One would
suspect such activities could produce MWCNTs.
1. Formation of Multiwall Carbon Nanotubes
from Fuel-Gas Burning Activities Indoors
In fact, MWCNTs and other fullerene-related multi-layer
shell structures were observed in samples collected from the
effluent stream of co-flowed flames of methane and air (Figures
6A and 6B) (Murr et al., 2004b). Bang et al. (2004) also found
MWCNTs and carbonaceous nanoparticles in aggregates of par-
ticulate matter collected from propane or natural gas (containing
96% methane) flames generated by typical kitchen stoves; the
aggregates had sizes ranging from 0.4 to 2 µm, putting them
in the respirable range. These aggregates were essentially pure
carbon or graphene and contained several hundred to several
thousand MWCNTs or other related nanocrystal forms with an
average diameter of 20 nm. The individual MWCNTs ranged
approximately from 3 to 30 nm in diameter (Murr et al., 2004a).
These findings indicate that MWCNTs and other carbonaceous
nanoparticles are produced also by water heaters, furnaces, and
household appliances powered by natural gas.
2. Multiwall Carbon Nanotubes in the Outdoor Environment
MWCNTs and carbonaceous nanoparticles (Figures 6C–6F)
were also observed in outdoor airborne particulate matter col-
lected in El Paso (Texas) and Houston (Murr et al., 2004b). The
aggregates were similar in structure to those collected indoors
except that the outdoor particulate matter also included agglom-
erates with other common atmospheric mineral nanocrystals,
such as silica.According toMurr et al. (2004a), about 15%of the
El Paso particulate samples were carbonaceous aggregates con-
sisting of MWCNTs and other nanoforms (shells, spheres, and
other structures). Diesel-related aggregates accounted for 5%
of the sample (Murr et al., 2004a). Murr’s group (Bang et al.,
2004) concluded that MWCNTs and carbonaceous nanoparti-
cles are ubiquitous in the environment; they further speculated
that MWCNTs are a major component of indoor and outdoor
airborne particulate matter.
3. Multiwall Carbon Nanotubes Were Combustion Products
of Ancient Anthropogenic or Natural Activities
MWCNTs and fullerene-like nanocrystal forms were also
observed in numerous particle aggregates in a sample of ancient
ice obtained from an ice core at the Greenland ice cap (Esquivel
and Murr, 2004; Murr et al., 2004b). The ice sample, from a
core drilled 1646 feet deep, was dated to roughly 10,000 years
old (placing it in the Neolithic Stone Age). According to Murr
et al. (2004b), the average diameter of the aggregates was <1
µm.Thesefindings show thatMWCNTsandother carbonaceous
nanoparticleswere present in airborne respirable dust aggregates
in the prehistoric environment.
4. Multiwall Carbon Nanotubes in Fine Particulate Matter
and the Implications for Public Health
The MWCNTs generated from fuel-gas combustion and
found in indoor and outdoor environments (Bang et al., 2004;
Murr et al., 2004a) are components of airborne particulate ag-
gregates less than 2.5 µm (PM2.5) in size. It has been well
established that the sources of PM2.5 include fuel combustion
from automobiles, power plants, wood burning, industrial pro-
cesses, and diesel-powered vehicles such as buses and trucks
(U.S. Environmental Protection Agency, 2003b). Combustion
processes typically generate very fine particles of sizes from
0.01 to 2.5 µm (Huggins et al., 2004), and combustion of fos-
sil fuels is the greatest contributor to fine particulates in the
air. The particulate matter contains elemental carbon, organic
carbon, trace elements, and common ions (U.S. Environmental
Protection Agency, 2003a).
Natural gas is considered an environmentally clean fuel and
produces less (7 lbs/billionBtu) particulatematter thanoil (84 lb)
or coal (2774 lb). However, because global fuel-gas consump-
tion is very large, the contribution of MWCNTs to air pollution
is very substantial. According to the National Energy Foun-
dation (National Energy Foundation, 2002), the United States
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FIG. 6. (A) A transmission electron microscope (TEM) image of a particulate matter (PM) sample collected from a combustion
stream of methane in the air. (B) High magnification of the area marked by the arrow in (A). (C) TEM image of an environmental
PM sample collected from El Paso (TX). (D) High magnification of the area marked by the arrow in (C). (E) TEM image of an
outdoor PM sample collected in Houston (TX). (F) High magnification of the area marked by the arrow in (E). Courtesy of L. E.
Murr of University of Texas at El Paso, TX, and A. Holian of University of Montana at Missoula, with permission for reprint from
Springer Publisher, Heidelberg, Germany (Murr et al., 2004a).
REVIEW OF CARBON NANOTUBE TOXICITY 199
consumed 22,096 billion Btu of natural gas in 1999; this ac-
counted for 27% of the global consumption. The consumption
of this “environmentally clean” fuel is expected to increase, and
the contribution ofMWCNTs to air pollutionwill be even greater
than before.
A study conducted by Harvard University (Boston) of mor-
tality rates in six U.S. cities showed an association between fine
particulate air pollution and excess mortality (Dockery et al.,
1993). In an American Cancer Society-sponsored epidemiolog-
ical study of 1.2million adults, Pope et al. (2002, 2004) reported
that fine particulate matter in ambient air is a risk factor asso-
ciated with cardiopulmonary mortality and cardiovascular and
pulmonary diseases. Gauderman et al. (2004) investigated the
effect of air pollution on the growth of lung function of chil-
dren during the period of rapid lung development that occurs
between the ages of 10 and 18. They found that adverse effects
on the lungs were associated with exposures to NO2, acid vapor,
fine particulate matter (PM2.5), and elemental carbon; elemen-
tal carbonwas shown to have the highest correlation (p = .007).
Concerns about health effects from exposure to fine particulate
matter of size <2.5 µm (PM2.5) prompted the U.S. Environ-
mental Protection Agency to revise the National Ambient Air
Quality Standards for particulate matter to include a standard
for PM2.5 (U.S. Environmental Protection Agency, 2003b). Be-
cause MWCNTs are present in airborne particulate aggregates
of respirable sizes generated from daily human activities and
they are likely to be present in significant levels in our environ-
ment (Murr et al., 2004a), it is reasonable to postulate that all
humans are exposed to CNTs.
It is true that much of the urban ambient PM2.5 is derived
from combustion of diesel fuel and gasoline, and not from com-
bustion of natural gas. However, if carbon atoms can be stripped
off from ethylene/pyrene during pyrolysis that producedMWC-
NTs (Che et al., 1998), and from methane and propane during
natural-gas combustion that generated MWCNTs, fullerenes,
and other carbon nanoparticles (Bang et al., 2004; Murr et al.,
2004a, 2004b), one could speculate that some of the carbon
atoms formed in the automotive combustion chamber fromgaso-
line (which contains mainly octane and other hydrocarbons)
could form MWCNTs. One may speculate that MWCNTs are
present in the soot of automotive exhaust. It is noteworthy that
the fine (<2.5 µm) PM samples that contained MWCNTs col-
lected in Houston were from an area in close proximity to a road
with heavy traffic (Murr et al., 2004b).
D. Comparison of Manufactured Carbon Nanotubes
and Fuel Combustion-Generated Carbon Nanotubes
In production ovens, CNTs are made in large amounts, al-
lowing van der Waals forces to be effective in driving the aggre-
gations of nanotubes into bundles, ropes, and clumps, most of
them probably larger than respirable sizes. The synthesis con-
ditions are also optimized to produce CNTs of a high degree
of uniformity and long fibers for practical applications (such as
spinning into threads or ropes). However, in the environment
outside the laboratory, where fuels are heterogeneous, combus-
tion conditions are various, and the reaction environments are
not confined, fuel-generated CNTs are expected to be highly
irregular in size and quality (Wikipedia, 2005). These factors
would reduce the effectiveness of van der Waals forces; the
MWCNTs produced would be less orderly, shorter in length,
fewer in numbers, and intermingled with other nanoparticles.
The physical differences between MWCNTs that are manufac-
tured and those that are combustion-generated (or found in the
ambient environment) are illustrated by comparing Figure 1F
with Figure 6. Figure 1F is an image of a laboratory sample
showing manufactured MWCNTs appearing like microscopic
ropes of length greater than a micrometer. Figure 6 shows en-
vironmental MWCNTs appearing like nanorods with lengths
varying within several hundred nanometers, and intermingling
with other nanoparticles. Murr’s group showed that sizes of par-
ticulate matter containing environmental MWCNTs were in the
respirable range (Murr et al., 2004a).
II. TOXICOLOGICAL STUDIES AND TOXICITY
OF MANUFACTURED CARBON NANOTUBES
A. Methodology to Assess the Potential Toxicity
of Carbon Nanotubes in the Lungs
When CNT synthesis moved from laboratories to factories
and the products became commercial commodities, there was
great concern about the toxicity of these light-weight fibrous
materials and their potential effects on workers (Gorman, 2002).
As pointed out earlier (section I.B.4), van der Waals forces
cause SWCNTs to have a strong tendency to bundle into micro-
scopic ropes, which may contain up to a few hundred parallel
tubes (Salvetat et al., 1999). These secondary structures, in turn,
form loose clumps, which can become airborne but are mostly
larger than respirable size (Figure 2F). These larger particulates
are not suitable for toxicology studies. To assess the potential
toxicity of a dust in the lungs, particles of respirable size have
to be isolated from the bulk material, or test materials have to be
mechanically processed into particles in the respirable range.
Aside from direct observations of the effects of a dust on
exposed human subjects, animal inhalation exposures are the
most appropriate means to assess toxicity of a dust in the lung.
As shown by the NIOSH aerosol scientists, it would be difficult
to isolate and collect enough fine CNT particles or clumps of
respirable size for an inhalation study (Baron et al., 2003). It is
also difficult to generate a controlled CNT concentration in a
chamber and monitor particle size and the actual exposure level.
Evenwithmore workable dusts or powders of other compounds,
the technical difficulty and cost associated with inhalation toxi-
city experimentation have led investigators to assess the effects
of these aerosols in the lungs by intratracheal instillation (ITI)
(Driscoll et al., 2000; Leong et al., 1998; Sabaitis et al., 1999).
If an animal is exposed to a test dust by inhalation, histopatho-
logical changes in the upper respirable tract can be examined, in
addition to assessing the effects in the pulmonary region. When
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dust is administered by ITI, a bolus dose of a fine dust suspension
is generally instilled into the trachea of a small animal and the
dust is assumed to be drawn deeper into the lung during breath-
ing. Besides having the disadvantage that this unnatural route of
administration could not be used to assess the effects of a test dust
in the upper respiratory tract, ITI also produces an artificial and
less even distribution of dust in the lung. Often, in an ITI study,
dust aggregates in aqueous suspensions need to be dissociated
or broken down to respirable sizes by ultrasonication with or
without a nontoxic dispersion agent. Moreover, the instilled bo-
lus dose may overwhelm the dust clearance mechanism, causing
the results to be exaggerated. However, an ITI study, designed
appropriately by including carefully chosen doses and reference
compounds of known inhalation toxicities, does allow the as-
sessment of the relative toxicity of the test material in respirable
sizes (Lam et al., 2002a, 2002b). ITI is an acceptable method
of screening dusts for potential pulmonary toxicity, provided
that the investigators or risk assessors recognize certain limita-
tions associated with this unnatural way of exposing animals to
dust (Driscoll et al., 2000). Dusts of comparable amounts (that
reached the lung parenchyma) given by inhalation or intratra-
cheal instillation were shown to produce similar toxicity in the
lungs (Henderson et al., 1995). All the animal studies conducted
so far to examine CNT pulmonary toxicity have been performed
by ITI or similar techniques.
B. Toxicity Studies of Carbon Nanotubes in the Lungs
Thefirst study of SWCNT toxicity, inwhich lung histopathol-
ogy in exposed mice was examined, was conducted to address
NASA’s concern that workers in occupational settings could be
exposed to the airborne dust of this novel material of unknown
toxicity (Lam et al., 2004). The study was also supported by
the Center of Nanoscale Science and Technology of Rice Uni-
versity; both organizations have facilities that make SWCNTs.
Parallel to the NASA study, Warheit et al. (2004) of Du Pont
Company (Wilmington, DE) conducted a toxicity study in rats
of a SWCNT product made by their company. Although the two
studies yielded some similar histopathological findings, the two
groups reached different conclusions about the toxicological risk
of exposures to SWCNTs; these have been the subject of wide
debate (Shvedova et al., 2005). Shvedova et al. of NIOSH sub-
sequently conducted a very comprehensive study in mice “to
resolve this conflict” (Shvedova et al., 2005). The toxicity of
MWCNTs had drawn little attention until very recently when a
group led by J. Muller of Faculte´s Universitaires Notre-Dame
de la Paix in Namur, Belgium (Muller et al., 2005), published its
study. All of these toxicological studies are outlined in Table 1
and are the subjects of this review.
1. Study of a Carbon Nanotube Product in Guinea
Pigs by Huczko et al.
The first published report on CNT toxicity was based on a
study conducted by Huczko et al. (2001) of Warsaw University
on two groups of five guinea pigs. Each animal was intratra-
cheally instilled once with 0 or 25 mg of CNT-containing soot in
0.5 ml saline (with Tween as a dispersing agent). After 4 weeks,
tidal volume, breathing frequency, and pulmonary resistance
were assessed. Bronchoalveolar lavage fluid (BALF) was ob-
tained from these animals for measurement of cell differentials
and total protein concentration. The investigators found no dif-
ferences between groups in the measured parameters, and con-
cluded that “the sootwith a high content ofCNTsdoes not induce
any abnormalities of pulmonary function or measurable inflam-
mation in guinea pigs treated with carbon nanotubes.” The au-
thors of this short communication,whichwas published in a non-
toxicology journal, further concluded that “working with soot
containing carbon nanotubes is unlikely to be associated with
any health risk.”However, examination of lung pathology,which
is the most critical toxicological endpoint of any pulmonary
toxicity study with dust, was not included in the study. Lung
pathology was examined in the other animal studies reviewed
later.
2. Study of Several Single-Wall Carbon Nanotube Products
in Mice by Lam et al.
For several years, NASA has had a facility that makes SW-
CNTs using the laser process developed by Rice University. At
the time (2000) this study was initiated, no toxicity data on this
material existed and NASA was concerned about its workers
being exposed to a novel material of unknown toxicity. Richard
Smalley’s group at Rice, also concerned about potential CNT
toxicity (Gorman, 2002), joinedNASA in support of our toxicity
study on SWCNTs.
To assess the pulmonary toxicity of CNT particles by ITI,
investigators must prepare the particles in respirable sizes. In
our study, the CNTs were prepared in mouse serum by brief ho-
mogenization (shearing) and ultrasonication (Lam et al., 2004).
Figure 7 shows light micrographs of CNT particles in serum
suspensions and shows that the predominate size of the parti-
cles was several micrometers; smaller particles were present but
could not be captured in light-microscope photographs. Parti-
cles of size about 1 µm were abundant under the microscope;
sizes smaller than 0.5 µm could not be detected or resolved by
lightmicroscopy. Characterization of theCNTparticles in serum
suspensions by scanning electron microscopy (SEM) was un-
successful because serum used as a dispersion agent for CNTs
interfered with SEM detection of CNT particles. Removal of
serum would change the particle dynamics and sizes in the sus-
pension. Using a transmission electron microscope, Shvedova
et al. (2005) reported that the dried images of nebulized CNT
suspension droplets (mass median particle diameter of ∼5 µm)
showed continuous mats of intertwined carbon nanoropes with
varying diameters. The actual sizes of these respirable CNT par-
ticles that reached the lung remained unknown.Becausewewere
interested only in finding out the toxicity of respirable-sized par-
ticles of SWCNTs in the lungs and not in investigating nanopar-
ticle toxicity, no efforts were carried out to make suspensions
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TABLE 1
Pulmonary toxicity studies of CNTs in animals and characteristics of these materials
Maker Synthetic Metal Animal Method of
Test materials of test materials process contenta species administration References
Soot containing
CNTs
Toyo Tanso Co. Ltd.,
Japan
Electric arc Co/Ni
No info on %
Guinea pig ITI Huczko et al., 2001
SWCNTs Rice University,
Houston, TX







Mouse ITFId Lam et al., 2004
SWCNTs, purified Rice University,
Houston, TX
HiPcob Fe: 2.1% Mouse ITFI Lam et al., 2004
SWCNTs CarboLex Inc.
Lexington, KY
Electric arc Ni: 26.0%
Y: 5.0%
Fe: 0.5%
Mouse ITFI Lam et al., 2004













Rat ITI Muller et al., 2005
aPercent by weight in final products.
bProcess developed by Rice University or originally developed by Rice University.
cInformation provided by D. Colbert of R. Smalley’s group at Rice University.
d Intratracheal fast instillation.
eIntrapharyngeal aspiration.
containing CNT particles predominately in nanosizes. More-
over, CNTs are very unlikely to exist in nanosizes in the air,
and the doses prepared in our animal study, by briefly (≤1 min)
ultrasonicating CNTs and suspending them in mouse serum at
FIG. 7. Light micrographs of sonicated suspended samples of (A) raw HiPco CNTs (0.1 mg/50 µl), and (B) purified HiPco CNTs
(0.5 mg/50 µl) showing the particles were predominately in respirable sizes (several micrometers or less).
concentrations of 0.1 mg/50 µl (equivalent to 2000 mg/L) and
0.5 mg/50 µl, were too concentrated for the particles to exist in
nanosize (Figure 7). As is routinely done when preparing CNTs
for physiochemical investigations, Smalley’s group at Rice used
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“aggressive sonication of purified NT samples in surfactants
such as Triton X or highly polar solvents like dimethyl for-
mamide” to make nanoparticle suspensions of 10 mg/L contain-
ing mostly individual fibers and a few small bundles (Walters
et al., 2001).
Pilot Study (Lam andMcCluskey, 2000 [unpublished report])
A pilot study was conducted on an early experimental SWCNT
sample made at Rice University by the laser ablation process
and containing about 10% nickel (by weight) and some iron
(information provided by D. Colbert of Rice University). In
this study, anesthetized mice (C57/BL/6J) were each intratra-
cheally instilled with 100 µl of mouse serum containing 0, 0.1,
or 1 mg of a CNT sample. Microscopic examination of the lungs
in the lower-dose group 1 week after the treatment showed min-
imal tissue reactions. However, the lungs of 5 mice treated with
the high CNT dose had focally severe foreign-body reactions
characterized by widespread prominent foci of particle-laden
macrophages and giant cells, and prominent peribronchial and
perivascular lymphocytic infiltrates (Figure 8B).
This high CNT dose killed some mice immediately after the
instillation; their respiratory distress apparently indicated that
mechanical blockage of the airways occurred, apparently from
the large volume (100 µl/mouse) of a bolus instillant. Because
a few animals died of suffocation in our pilot study, in our core
study we reduced the volume of the dose to 50 µl/mouse and
modified the instillation technique (Lam et al., 2004) by adopt-
ing the intratracheal fast instillation of Sabaitis et al. (1999).
We also replaced parenteral ketamine/xylazine anesthetic with
isoflurane inhalation anesthetic to achieve quick anesthesia in-
duction and reduce mucus production. No more deaths from air-
way blockage occurred. Because the low dose in our pilot study
produced only minimal effects in the lung, we halved the high
dose and used these two doses (0.1 and 0.5 mg/50 µl/mouse)
for our core study.
Core Study (Lam et al., 2004) Because the CNT sample
used in the pilot study contained a substantial amount of nickel,
and nickel is highly toxic, we could not with certainty ascribe
the lung lesions to CNT itself. To more definitively character-
ize the intrinsic toxicity of CNTs and the influence of metals
in the toxicological manifestation of the test compounds, we
followed the pilot study with a core study of three CNT prod-
ucts made by different manufacturing processes and containing
different types and/or amounts of residual metals (Lam et al.,
2004). When this study was initiated, Rice had shifted from
the laser process to the HiPco process for synthesizing CNTs.
The study was conducted on (1) unprocessed iron-containing
SWCNTs made by the new HiPco process, (2) a purified HiPco
product that had been vigorously treated with concentrated acid
to remove metal residues by the method published by Rinzler
et al. (1998), and (3) a CarboLex SWCNT sample, made by an
arc-discharge process, that contained nickel and yttrium (Ta-
ble 1). Included in the core study were two standard reference
materials: ultra-fine carbon black (Printex 90, a dust with rela-
tively low toxicity inmice) and quartz (Min-U-Sil-5, a fibrogenic
dust). Groups of B6C3F1 mice (4/group for 7 days, 5/group for
90 days) were intratracheally instilled with a test-dust suspen-
sion (0, 0.1, or 0.5 mg/50 µl/mouse, respectively equal to about
0, 3.3, or 17 mg/kg) and were euthanized 7 or 90 days after the
single treatment. The lungs were excised, fixed, and stained for
histopathological study (Lam et al., 2004).
All CNT samples tested, regardless of the type and amount
of metal impurities they contained, induced dose-dependent le-
sions characterized chiefly by interstitial granulomas (micro-
scopic nodules) in the lungs of mice in the 7-day (Figures 8C
and 8D) and 90-day groups (Figures 8E and 8F) (Lam et al.,
2004). The granulomas were located beneath the bronchial ep-
ithelium and were present throughout most of the microscopic
fields of lung tissue. The lungs of all the mice that received
high doses of CNTs had prominent granulomas. Granulomas
were less prominent but were still observed in the mice treated
with the low dose of HiPco-synthesized CNTs; they were not
seen in the groups treated with the low dose of graphite arc-
derived CNTs that contain lower content of SWCNTs. The find-
ings were similar to those observed in the mice treated with a
laser-synthesized CNT product produced in our pilot study; the
pathology team of the pilot study described lung lesions as fo-
cally severe foreign-body reactions characterized bywidespread
prominent foci of particle-laden macrophages and giant cells
(Figure 8B). The lung lesions in the 90-day high-dose groups
were generally more pronounced than those in the 7-day high-
dose groups (compare Figures 8C and 8D with Figures 8E and
8F). In the 90-day high-dose groups, many more lymphocytes
were seen and fibrosis was more evident (Figures 8E and 8F);
the lungs of some of these animals showed severe peribronchial
and interstitial inflammation, fibrosis, and necrosis that had ex-
tended into the alveolar septa.
As expected, the lungs of mice in the serum control groups
were normal. The mice treated with the high dose of quartz
showed mild to moderate pulmonary inflammation. This mani-
festation of quartz-induced toxicity was considered less severe
than lesions induced by CNTs. Mice in the group treated with
carbon black had black particles in alveolar regions, with mini-
mal tissue reactions (Figure 8A).
3. Study of a Single-Wall Carbon Nanotube Product
in Rats by Warheit et al.
Using a different rodent species, Warheit et al. (2004) of Du
Pont Company also showed that CNTs produced granulomas
in the lungs. This ITI study in Sprague-Dawley rats was con-
ducted on a laser-synthesized SWCNT product that contained
5% nickel and 5% cobalt. The sample consisted of SWCNT
ropes, each ∼30 nm in diameter. According to Warheit, this
CNT sample was produced by the Rice laser ablation process
(Rinzler et al., 1998). In 2002, DuPont obtained this manufac-
turing method from Carbon Nanotechnologies, Inc., which was
cofounded by Richard Smalley of Rice University (Cui et al.,
2000). This same process was used to make the laser CNT sam-
ple that was provided by Rice to NASA for its pilot study (Lam
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FIG. 8. Lung tissues from mice intratracheally instilled with 0.5 mg/mouse [1 mg/mouse for (B)] of a test material and euthanized
7 or 90 days after the single treatment. (A) Carbon black, 7 days. Particles were scattered in alveoli, and no tissue reaction was
observed. (B) Rice University laser-produced carbon nanotubes (CNTs), 7 days. Widespread prominent foci (focal granulomas)
contain CNT- laden macrophages. (C) CarboLex arc-produced CNTs, 7 days. Focal granulomas were present. (D) Unprocessed
HiPco CNTs, 7 days. The figure shows a well-defined granulomawith some fibrosis (thickening) of alveolar walls. (E) Unprocessed
HiPco CNTs, 90 days. A picture of a large nodular lesion shows fibrosis, necrosis, and surrounding tissue, all of which represent
a severe reaction. (F) Purified HiPco CNTs, 90 days. Nodular tissue shows fibrosis and necrosis; tissue in this area had very little
normal parenchymal structure. Magnifications 40 to 200× (Lam et al., 2004).
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and McCluskey, 2000) (unpublished report). Warheit’s labora-
tory examined histopathology in the lungs and biomarkers of
toxicity in BALF. Graphite powder (particle sizes <1 µm and
having the same amount of incorporated metals as CNTs) and
quartz were used as negative and positive control dusts. The
animals were given the test material (suspended in phosphate-
buffered saline with 1%Tween 80) at 0, 1, or 5mg/kg (0, 0.25, or
1.25mg/rat). The animals were euthanized for histopathological
examination of the lungs at 1, 7, 30, or 90 days after the single
treatment. Multifocal granulomas became evident 1 month after
exposure (Figures 9C and 9D). The authors stated that gran-
ulomatous lesions in the lungs of the CNT-treated rats were
non-dose-dependent, nonuniform, and nonprogressive. On the
other hand, quartz was observed to produce cytotoxicity, inflam-
mation, and fibrosis in a dose-dependent fashion. Graphite that
contained amounts of nickel and cobalt equal to those of the
CNT sample produced no signs of toxicity in the lungs.
The turnover of lung parenchymal cells was assessed in
groups of rats euthanized at 1, 7, 30, or 90 days after the single-
dose dust treatment. Six hours before they were killed, the an-
imals were injected with bromodeoxyuridine (a modified DNA
base) to examine the extent of DNA synthesis in lung cells. The
results showed no statistically significant change in cell-labeling
indices of any CNT-treated group. Significant increases in cell
proliferation indiceswere detected in rats treatedwith high doses
of quartz and euthanized at 24 h and 1 month.
Study of the BALF showed that quartz at a high dose pro-
duced an increase in lactate dehydrogenase (LDH) and protein
concentrations at all time points; SWCNTs induced only a tran-
sient increase in the 1-day group. Quartz at a high dose produced
an increase in LDH and protein concentrations at all time points.
The findings of no dose-dependent and no time-dependent
granulomatous response, and absence of prolonged inflam-
mation in the lungs, led Warheit et al. to conclude that the
granulomatous reaction was a nonspecific response to instilled
aggregates of SWCNTs and that the results “may not have phys-
iological relevance, and may be related to the instillation of a
bolus of agglomerated nanotubes” (Warheit et al., 2004).
4. Study of a Single-Wall Carbon Nanotube Product
in Mice by Shvedova et al.
Both Lam et al. (2004) and Warheit et al. (2004) found that
CNTs produced lung lesions, including granulomas, but the two
groups reacheddifferent conclusions regarding thepotential haz-
ard of exposures to SWCNTs. To address this difference in tox-
icological assessments, Shvedova et al. (2005) of NIOSH car-
ried out a pulmonary toxicity study in mice (C57CL/6). The
study was conducted on a purified HiPco CNT product (>99%
SWCNTs) that was exhaustively purified by the NASA JSC
nanomaterials group to remove metals (final iron content 0.23%
by weight) (Figure 3B). The animals were given a single treat-
ment of CNTs, carbon black, or quartz at a dose of 0, 10, 20,
or 40 µg/mouse (about 0, 0.5, 1, or 2 mg/kg). Aqueous sus-
pensions of test dusts were aspirated at the pharyngeal area of
mice, allowing droplets to be pulled into the lung during inspi-
ration. The mice were then killed 1, 3, 7, 28, or 60 days after the
treatment. Histopathological examination of the lungs showed
an acute inflammation, early onset of formation of granulomas,
and progressive fibrosis. The histopathology was characterized
by SWCNT-induced granulomas, mainly associated with hy-
pertrophied epithelial cells surrounding the dust aggregates, and
diffusive interstitial fibrosis and alveolar wall thickening likely
associated with dispersed SWCNTs. The total mass of granu-
lomas in the lungs of mice in the 60-d group increased with
an increase in the CNT dose (Figures 10A and B). In general,
lung lesions were dose-dependent and progressive, like those
reported by Lam et al. (2004). Judging by the published micro-
graphs of lung histopathology, the granulomatous lesions in the
mice treated with purified HiPco CNTs in Lam’s study (Lam
et al., 2004) were more prominent than those reported by Shve-
dova et al., who also used a purified HiPco CNT sample but with
a dose range about an order ofmagnitude lower (Shvedova et al.,
2005). Shvedova et al. further reported that there was significant
damage to pulmonary cells. An increase of alveolar type II (AT-
II) cells, the progenitor cells that replicate following AT-I cells’
death, was detected. Pulmonary function tests showed increases
in functional respiratory deficiencies with increased concentra-
tions of CNTs, a finding consistent with fibrosis. Comparedwith
saline-treated controls, CNT-treated mice showed slower bacte-
rial clearance assessed7days after bacterial inoculation.At these
test doses, quartz and carbon black did not induce granulomas
or fibrosis.
To confirmWarheit’s BALF findings, Shvedova et al. (2005)
also examined the biomarkers of toxicity in the lavaged fluid
from CNT-treated mice. The results mostly disagreed with
Warheit’s findings, showing increases in total protein con-
centration, cell counts, concentration of transforming growth
factor beta (TGF-β), lactate dehydrogenase (LDH), and γ -
glutamyltranspeptidase activities, and glutathione depletion;
these biomarkers of inflammation, oxidative stress, or cytotoxic-
ity in the lungs were dose-dependent. Shvedova et al. concluded
that crystalline silica caused less cytotoxicity than CNTs (com-
pared on an equal-weight basis) and recruited fewer polymor-
phonuclear leucocytes into the lungs. Like Lam et al. (2004),
Shvedova et al. (2005) demonstrated that CNTs were intrinsi-
cally toxic and cautioned that exposure of workers to respirable
SWCNT particulate matter may pose a risk of developing lung
lesions.
5. Study of a Multiwall Carbon Nanotube Product
in Rats by Muller et al.
MWCNTs have been shown to produce lung lesions simi-
lar to those observed in studies with SWCNTs. Muller et al.
(2005) tested two forms of MWCNTs, unprocessed MWCNTs
and MWCNTs that had been ground. They reported that 60
days after rats (Sprague-Dawley) were each given a single ITI
dose of 0.5, 2, or 5 mgMWCNTs (sonicated and suspended in a
normal saline solution containing a dispersing agent, Tween 80),
REVIEW OF CARBON NANOTUBE TOXICITY 205
FIG. 9. (A, B) A granuloma in a mouse lung 90 days after instillation with 0.5 mg HiPco SWCNT/mouse showing CNT fibers
(Lam et al., 2004). (C) Multifocal granulomas in lung tissue from a rat instilled with 1 mg/kg of laser-produced SWCNTs and
microscopically examined 1 month after the treatment. (D) High magnification of a granuloma in (C); the CNTs in the granuloma
show fibrous structure. (E) Granulomas that appeared in lung of a rat 60 days after it was instilled with 2 mg/rat of an MWCNT
suspension. (F) A granuloma at high magnification. (C) and (D) are courtesy of Warheit et al. (2004) with reprint permission from
Oxford University Press (Oxford, UK); (E) and (F) are courtesy of Muller et al. (2005), with permission for reprint from Elsevier
Publishing Co. (Philadelphia, PA).
their lungs showed inflammation, granulomas, and fibrosis (Fig-
ures 9E and 9F). The unground CNTs remained in the bronchial
lumen and produced collagen-rich granulomas. The bronchial
lumen was partly or completely blocked, likely an effect similar
to that observed by Warheit et al. (2004); very few CNT parti-
cles were seen in the parenchymal (alveolar) region. The ground
CNTs were “better dispersed” in the parenchyma, and in the in-
terstitium they induced granulomas consisting of macrophages
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FIG. 10. (A) Morphometric measurement of connective and cellular tissues of mouse lung sections 28 days after postpharyngeal
aspiration of 10–40 µg SWCNTs/mouse (open bar, granulomatous cellular tissue; gray bar, granulomatous connective tissue;
black bar, alveolar connective tissue). Inset: morphometric changes in connective tissue of alveolar wall regions in response to
SWCNT (10–40 µg/mouse) 28 and 60 days posttreatment (, 28 days; , 60 days); means± SE (n = 6 mice/group). α p < .05 vs.
PBS-treated control mice; β p < .05 vs. mice treated with 10 µ g/mouse SWCNT. (B) TEM of lung interstitium shows deposition
of collagen and elastin (Shevdova et al., 2005). (C) Hydroxyproline and (D) collagen content of rat lungs 60 days after they were
instilled with MWCNTs (ground or unground; 0.5, 2, or 5 mg/rat), asbestos (Asb, 2 mg/rat), or carbon black (CB, 2 mg/rat). CNTs
induced a dose-dependent increase of hydroxyproline and collagen production in the lung of treated animals (Muller et al., 2005).
(A) and (B) are courtesy of A. Shvedova of NIOSH with reprint permission from the American Physiological Society (Bethesda,
MD). (C) and (D) are courtesy of J. Muller, with permission for reprint from Elsevier Publishing Co. (Philadelphia, PA).
laden with particles, multinuclear giant cells, and some inflam-
matory cells, like those discussed earlier (Lamet al., 2004; Shve-
dova et al., 2005; Warheit et al., 2004) that were reported for
SWCNTs. Muller et al. (2005) also showed that hydroxypro-
line and soluble collagen, two biomarkers of fibrosis, increased
in the lung tissues in a dose-dependent fashion (Figures 10C
and 10D), like that reported by Shvedova et al., 2005. BALF
obtained from rats 3 days after the CNT treatment showed dose-
dependent increases in LDH activity, total protein concentra-
tion, and neutrophil number. Muller et al. (2005) also concluded
that CNTs are potentially toxic and advocated strict industrial
hygiene.
C. Effects of Single-Wall Carbon Nanotubes
in the Mouse Heart
Shvedova’s group at NIOSH also examined mitochondrial
DNA in the aortas of animals that received CNTs by pharyngeal
aspiration (Li et al., 2005); they reported dose-dependent dam-
age to the DNA at 7, 28, and 60 days after the CNT treatment.
They concluded that these oxidative changes were the result of
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altered expression of inflammatory genes, includingMCP-1 and
VCAM-1, in the heart. To further examine the effects of CNTs
in the heart, 10 hypercholesterolemic (ApoE-/-) mice were each
instilled pharyngeally with a total dose of 20 µg SWCNTs for
8 weeks (once every other week). At the end of exposure, Li
et al. (2006) observed that the percent of aortic area covered by
plaquewas significantly increased in theCNT-treatedmice com-
pared with the vehicle-treated controls. Morphometric analysis
revealed a significant increase of atherosclerotic lesions in the
brachiocephalic arteries of the CNT-treated mice. The authors
concluded that the effects in the heart might be caused by cy-
tokines released from the inflammation areas in the lungs and/or
by CNTs that leave the lungs and enter the systemic circulation
(Li et al., 2005, 2006).
D. Effects of Carbon Nanotubes on Skin Cells
in In Vitro Culture Systems
1. Human Skin-Cell Study with a Single-Wall Carbon
Nanotube Product
The effect of SWCNTs on skin cells in culture was investi-
gated by Shvedova et al. (2003). Immortalized human epidermal
keratinocytes (HEKs) were incubated (37◦C) with raw HiPco
CNTs [containing 30% iron, and similar to the raw HiPco prod-
uct used by Lam et al. (2004)] at 0.06, 0.12, or 0.24 mg/ml
for 18 h; cell homogenates were then prepared and assayed. In
the cells treated with SWCNTs, the authors observed formation
of free-radical species, accumulation of peroxidative products,
reduction of total sulfhydryls, and a decrease in content of vi-
tamin E. The observed effects were dose dependent. Because
some iron compounds are known to induce oxidation or perox-
idation in cells, the authors attributed these oxidative effects to
the iron in the carbon nanotubes (Shvedova et al., 2003). This
conclusion seems inconsistent with the findings on MWCNTs
of Monteiro-Riviere et al. (2005), discussed next. In an animal
study conducted later, Shvedova et al. (2005) found iron-free
CNTs were capable of producing these cytotoxic effects (sec-
tion II.B.4). The role of iron in CNT-induced cytotoxicity would
need further investigation.
2. Human Skin-Cell Study with a Multiwall Carbon Nanotube
Product
Monteiro-Riviere et al. (2005) tested a MWCNT product on
HEKs; the doses were 0.1, 0.2, and 0.4 mg/ml, and incuba-
tion time was up to 48 h. Uptake of particles by the HEKs was
demonstrated by transmission electron microscopy. The cells
in the 0.4-mg/ml culture were found to release the proinflam-
matory cytokine interleukin 8 in a time-dependent fashion. The
elemental analysis of cells showed that the particles did not
contain iron (iron nanofilms were used to induce MWCNT for-
mation).Monteiro-Riviere and colleagues concluded that the ef-
fects of MWCNTs on the cells were not caused by the catalytic
metal.
III. DISCUSSION
A. Highlights of the Pulmonary Toxicity
Studies—Agreements and Disagreements among the
Investigator Groups on Potential Health Risk
of Exposure to Manufactured Carbon Nanotubes
Lam et al. (2004) conducted a study in mice given three
SWCNT products made by different methods and containing
different types and amounts of residual catalytic metals. The au-
thors concluded that collectively CNTs induced dose-dependent
and time-dependent interstitial inflammation, and epithelioid
granulomas. They also concluded that, if CNTs reached the
lungs, they could be rather toxic, even more than quartz on an
equal-weight basis, and cautioned that a human exposure risk
exists. Warheit et al. conducted a similar study in rats and also
found that CNTs induced granulomas, but they did not observe
prolonged inflammation and fibrosis. The findings that the gran-
ulomatous lesions were non-dose-dependent and nonprogres-
sive, and that there was no prolonged inflammation, led Warheit
et al. to conclude that the granulomatous reaction was a non-
specific response to instillation of a bolus dose of agglomerated
SWCNT aggregates. The fact that CNTs have a strong tendency
to aggregate, coupled with the finding that some instilled CNTs
lodged in the major airways and the mechanical blockage suf-
focated 15% of the high-dose group, led Warheit to conclude
that these toxicological results may not be relevant to human
exposures.
As pointed out by Shvedova et al. (2005), the differences in
results and interpretations of these two studies led to great debate
on toxicological hazards of CNTs. Thus, Shvedova et al. con-
ducted an extensive study “to resolve this conflict.” The results
of this NIOSH study showed that CNTs produced an unusual
acute inflammation, early onset of formation of granulomas, and
progressive fibrosis in CNT-exposed mice. Besides being pro-
gressive, the lung lesions were also dose dependent, like those
reported by Lam et al. (2004). In addition, these NIOSH inves-
tigators also showed that CNTs produced dose-dependent func-
tional respiratory deficiencies and impaired bacterial clearance
in the lungs. The test doses of quartz and carbon black did not in-
duce granulomas or fibrosis, or impair lung functions. Shvedova
et al. also examined the biomarkers of toxicity in the BALF from
CNT-treated mice; the results mostly disagreed with Warheit’s
findings in rats (see sections II.B.3 and II.B4.). Like Lam et al.
(2004), Shvedova et al. (2005) demonstrated that CNTs were
intrinsically toxic and cautioned that exposure of workers to res-
pirable SWCNT particles may pose a risk that they will develop
lung lesions.
The findings of nonprogressive and non-dose-dependent
granulomas coupled with the absence of fibrosis and associ-
ated biomarkers of cell injury and inflammation in BALF led
Warheit et al. to conclude that CNTs did not follow the nor-
mal paradigm of other toxic dusts and the lesions were due to a
nonspecific response to instillants. Commenting on these find-
ings, Dreher (2004), on the other hand, speculated that a new
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mechanism of pulmonary toxicity and injury was possible with
CNTs. In testing Warheit’s hypothesis, Shvedova et al. (2005)
found progressive and dose-dependent fibrotic changes in CNT-
treated mice; they also showed in the BALF that CNTs induced
an “unusual” and “robust” acute inflammation (did not persist
over 2months after CNT treatment), oxidative stress, and release
of toxic cytokines in a dose-dependent fashion.
One of the possible reasons why Warheit et al. (2004) failed
to observe a progression and dose and time dependence of lung
lesions may be that a substantial fraction of the instilled bo-
lus dose did not reach the alveolar region where the lesions
occur. The fractional loss of instillant to major airways was sub-
stantial because the mechanical blockage killed 15% of rats in
the high-dose groups. For survivors, in some cases even after
3 months, some of the CNT instillant remained as large bo-
luses and had not transited the airways into the alveolar region
(Warheit et al., 2004).
We also observed that instillants mechanically blocked the
airways in our pilot ITI study (Lam et al., 2004), resulting in
animal deaths when the mice were each given a bolus dose of
a 1 mg/100 µl CNT suspension. However, after we reduced the
dosing volume of the instillant and changed the dosing tech-
nique from ITI to intratracheal fast instillation (modified from
the method initially developed by Sabaitis et al., 1999), we did
not lose another mouse because of CNT administration and did
not see CNTs remaining in the airways. Shvedova et al. (2005),
who used the pharyngeal aspiration technique in their large-scale
(∼1000 animals) study, did not report animal deaths or CNTs
not entering the alveolar region. In their rat study similar to the
study ofWarheit et al., Muller et al. (2005) also saw blockage of
respirable airwayswhen suspensions of unprocessed (unground)
MWCNTswere instilled, but found instilled groundCNTs in the
alveolar region. Thus, the ability of the administered material to
reach the target area depends on dosing technique, sample prepa-
ration, and choice of dispersion agent. If air contains CNTs in
small enough sizes, they will reach the pulmonary region.
B. Carbon Nanotubes Themselves Caused Lung Lesions
in the Treated Rodents
Lam et al. used a Rice HiPco product (using iron as a cata-
lyst) that was treated vigorously to remove iron, and showed that
this purified CNT product (residual iron content 2.3%) produced
inflammation, granulomas, and fibrosis in the lungs; they con-
cluded that CNTs themselves produce these lung lesions (Lam
et al., 2004). The conclusions were supported by the results of
Shvedova et al. (2005), who also used a purified HiPco prod-
uct that contained only 0.23% iron and<1% amorphous carbon
(99.7% of the carbon in the product had nanotube morphology);
this product was reported to produce “unusual inflammatory and
fibrogenic pulmonary responses.” Residual iron nanoparticles in
HiPco products are generally covered by carbon shells. In the
purification process, iron is removed by repeated processes of
oxidation of carbon to expose iron followed by strong acid treat-
ment to remove iron (Chiang et al., 2001). Using electron para-
magnetic resonance (EPR) spectroscopy, Shvedova et al. (2005)
were able to detect iron signals from unpurified HiPco products
but not from the purified sample used in their study. Warheit
et al. (2004) found that CNTs but not graphite (both contained
5% nickel and 5% cobalt) produced granulomas in the lung of
exposed rats.
C. Toxicity of Different Manufactured Carbon Nanotube
Products—Methods of Synthesis and Impurities
1. Methods of Synthesis and Impurities in Carbon Nanotubes
The toxicity studies collectively showed that all of the CNT
products tested, regardless of the method of synthesis, could
induce inflammation, granulomas, and fibrosis in the lungs of
treatedmice or rats. As pointed out in the previous section, CNTs
themselves produced these lung lesions. However, the presence
of impurities might affect the severity of lesions (Lam et al.,
2004). Depending on the manufacturing processes and postsyn-
thetic purification, both the non-nanotube carbon and the metal
residues in a CNT product can vary greatly (Table 1 and section
I.B.3). For example, raw SWCNT products currently sold by
SES Research (Houston, TX) contain only 20–40% nanotubes
with the remainingmaterial consisting ofmetal catalyst, carbon-
coatedmetal nanoparticles, amorphous carbon, and other carbon
nanoparticles (SES Research, 1999); the purified HiPco sample
used in the study by Shvedova et al. (2005) contained < 1%
non-nanotube carbon and 0.23% iron. Since 1 g of a purified
HiPco product contains about 3 times more CNTs than the
same weight of a raw SWCNT product of SES Research, an
equal amount of these two products will be expected to pro-
duce different degrees of toxic insults to the lungs of treated
animals.
2. Metal Contents in Carbon Nanotubes and Cautions
in Assessing Toxicity of Metals in the Products
The metal particles are the sites of SWCNT synthesis. The
content of residual catalytic metals in a raw CNT product can be
as high as 50% (Table 1). The metals themselves, such as nickel,
could have toxic effects in the lungs, and one may wonder if
some of the lesions could be attributed to the metals in CNT
products. These metal nanoparticles, which are 3–5 nm in size,
are “encased in thin carbon shell and distributed throughout the
sample” (Figure 3) (Chiang et al., 2001). The encased metal
would not be expected to interact with cells. However, Lam et al.
(2004) observed that a dose of 0.5mg/mouse ofCNTs (sonicated
suspension) containing 26% nickel and 5% yttrium killed about
50% of the animals within 7 days after dosing. The deaths were
attributed to nickel that was released during ultrasonication.
It has been suspected that ultrasonication of CNT suspensions
may release themetals from carbon entrapment or encapsulation
allowing them to come into contact with lung cells to elicit toxi-
city. In a study of cell cultures treated with a raw HiPco product
(∼25–30% iron), Shvedova et al. (2003) attributed the oxida-
tive and peroxidative changes they observed to the iron in the
product. In a subsequent animal study, Shvedova et al. (2005)
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used a highly purified HiPco sample (0.23% iron) and showed
that CNTs produced a dose-dependent increase in biomarkers
associated with inflammation and oxidative stress in the lungs.
The inflammatory and oxidative reactions in the lungs were thus
attributed to the CNTs themselves. Therefore, caution should
be exercised in assessing the effects of metals contained in CNT
samples in intratracheal instillation and cell-culture studies
that involve ultrasonication. Investigators who use residual
metal in CNTs to measure the half-life of instilled CNTs in the
lungs (Muller et al., 2005) also should be aware that the metal
nanoparticles may be freed by ultrasonication from the carbon
shells or CNT entrapment, leading to a difference in half-lives
between the tracer metal nanoparticles and CNT fibers in the
lungs.
D. Possible Mechanisms of Carbon Nanotube
Pathogenesis in the Lungs and Toxicological
Difference From Carbon Black
When instilled into the lungs, both carbon black (CB) and
CNT particles were taken up by alveolar macrophages, but their
fate and reaction with the lung tissue were very different (Lam
et al., 2004). CB-laden macrophages remained scattered in the
alveolar space. It is well known that if the lung is not overloaded
with dust, dust-laden macrophages on the alveolar surface will
migrate upward and be carried by the mucociliary escalator sys-
tem up the trachea, and cleared into the esophagus (McClel-
lan, 1997a). CNT-laden macrophages, however, moved rapidly
to centrilobular locations, where they entered alveolar septa and
clustered to form epithelioid granulomas.When a dust enters the
interstitial or subepithelial space, clearing it from the lung is very
difficult. Thus, if a biopersistent dust is irritating or toxic, the le-
sions resulting from the persistent interaction between the cells
and the dust trapped in the interstitium will generally worsen
with time, as was observed for CNTs by Lam et al. (2004) and
Shvedova et al. (2005).
1. Surface Chemistry, Electrical Properties, and Oxidative
Potential of Carbon Nanotubes
CNTs are known to possess unique surface chemistry; we
have pointed out that their unusual chemical and electrical prop-
erties could contribute to the toxicity of CNTs (Lam et al.,
2004). According toRichard Smalley’s group at RiceUniversity,
SWCNTs are among the best electrical conductors and can con-
duct electricity twice as well as copper (Rice University, 2005).
SWCNTs have unique electron-transport properties; they may
be either metallic (armchair configuration) or semiconducting
(zigzag configuration), determined by the chiral vector of the
tubes (Jensen et al., 2004). In a typical batch, one-third of the
SWCNTs are metal conductors and two-thirds are semiconduc-
tors (Stahl, 2000; Watts et al., 2002). Carbon black is devoid
of this chemical/electrical property. It is conceivable that CNTs
may participate in oxidative and peroxidative reactions by re-
moving electrons from or shifting electrons around in the cells.
Shvedova et al. (2005), who used a highly purified HiPco prod-
uct containing only trace levels of iron, detected robust acute
inflammation, which was characterized by biochemical toxicity
changes including accumulation of 4-hydroxynonenal (an ox-
idative biomarker), elevation of proinflammatory cytokines, and
depletion of glutathione. It is very likely that the unique electron
transport property of CNTs is the culprit in inducing oxidative
inflammation in the lungs. The nanotechnology field discovered
a potentially very useful property in this tubular molecule made
of a nonmetal element and able to conduct electricity. The unique
property of being able to remove or provide electrons may also
enable CNTs to participate in cellular oxidative processes that
could result in unanticipated toxicity.
2. Fibrous Structure of Carbon Nanotubes
Carbon black is amorphous, but CNTs microscopically are
thin fibers packed tightly and in parallel to form ropes or rods
(Figures 1B and 1F) (Taubes, 2002; Unrau, 1996). As defined
in Comprehensive Toxicology,“Fibers are a special class of par-
ticles defined as elongated objects whose aspect ratio, the ra-
tio of the object’s length to its diameter, is greater than three”
(McClellan, 1997a). Therefore, toxicologically, individual nan-
otube molecules and assembled nanotube ropes, rods, and bun-
dles are fibers. The fibrous structures of the CNT particles were
clearly seen in the lungs in our study (Figures 9A and 9B) and
Warheit’s study (Figure 9D). It is reasonable to expect that it
would be more difficult for macrophages to safely engulf rel-
atively rigid and fibrous CNT structures, especially if some of
them can conduct electrons (Smalley, 1999); rigid or semirigid
electronically active fibers can potentially perforate cell mem-
branes and could disturb cellular functions, resulting in toxicity
and even cell death. We did observe necrosis in the lungs (Lam
et al., 2004), and Shvedova et al. (2005) observed an indication
of an increase of AT-1 cell death in the lungs of mice treated with
CNTs. It is well known that the geometry of particulate matter
plays an important role in pathogenesis caused by the parti-
cles. CNTs are totally insoluble and probably one of the most
biologically non-degradable man-made materials. It is well es-
tablished that the pathogenicity of a fiber in the lungs directly
correlates with its biopersistency (McClellan and Hesterberg,
1994; Oberdorster, 2000).
E. Particle Size Issues of Manufactured Carbon
Nanotubes Studied Toxicologically
It is well known that the particle size of a dust has great
influence on its toxicity, not only on the location of its deposition
in the respiratory tract, but also on how it interacts with the target
cells (Oberdorster et al., 2005). Even for a respirable dust (dust
that can reach the alveoli) on an equal-weight basis, toxicity
generally is greater with smaller particle size (Oberdorster et al.,
1994). One mg of a dust of d = 0.1 µm has 1000 more particles
than the same weight of a dust with d = 1 µm [m = v × ρ =
(1/6)d3 × ρ, where m is mass, ρ is density, and volume (v) of
a spherical particle = ((4/3)r3) = (1/6)d3], and more particles
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provide greater surface area for physical contact between cells
and the dust.
Because of the van der Waals force attraction, CNTs bun-
dle into ropes, which are further associated into loose aggre-
gates. We prepared CNT suspensions by brief shearing (2 min)
of the agglomerates in serum followed by brief (1 min) soni-
cation. As shown in light micrographs in Figure 7, the bulk of
the HiPco-CNTs in a suspended test sample existed predomi-
nately in length of several micrometers. Lam et al. (2004) and
Shvedova et al. (2005) both used ultrafine carbon black (Printex
90), which has a median particle size of 14.3 nm, as a reference
dust in their studies, and showed that CNTs, but not ultrafine car-
bon black, produced lung lesions. Shvedova et al. also pointed
out that “the interstitial fibrotic response to SWCNTs was not
mimicked by an equivalent mass exposure to either ultrafine car-
bon black (a reference nanoparticle) or fine crystalline silica (a
classic fibrogenic particle).” Therefore, the reported differences
between these two carbon allotropes in lung toxicity were at-
tributed to their difference in other physicochemical properties
and not their size difference. That is to say, the observed toxic-
ity of CNTs was not due to the fact that CNT particles were in
nanosizes. Because none of the investigators of the animal stud-
ies discussed here showed that they had prepared CNT particles
in nanosizes, it is noteworthy that none of the CNT toxicity stud-
ies reported so far were investigations of nanoparticle toxicity of
CNTs, but rather of toxicity of respirable particles of materials
of great importance to nanotechnology.
F. Toxicological Risk Assessment of Occupational
Exposures to Manufactured Carbon Nanotubes
The risk assessment of human health effects from exposure
to a chemical is a complicated and difficult process, and the
process is continuously refined by filling data gaps with new
research data (McClellan, 1999). When potential exposure is
by the inhalation route, the target is the lung, and the chemical
is a fibrous dust, the risk assessment takes an even more diffi-
cult path (McClellan, 1997b), as in the case of CNTs. The CNT
manufacturing industry is still in its infancy and the produc-
tion volume is still small. Data pertaining to CNT toxicity from
human exposures will not be available for many years; results
from inhalation studies will not be available for some time. The
current lack of data from human exposures and animal inhala-
tion toxicity studies makes the assessment here, which is based
on toxicological data sets obtained from administering CNTs to
animals intratracheally or by modified routes, preliminary. The
discussion here of the existing toxicity data follows the National
Research Council’s risk assessment scheme (National Research
Council, 1994), including identification of data gaps for further
research (McClellan, 1999).
1. Hazard Identification
The animal studies of CNT pulmonary toxicity collectively
showed that CNTs are capable of inducing inflammation, epithe-
TABLE 2
Incidence of pulmonary lesions in mice 90 days after
intratracheal instillation with carbon nanotubesa
Dust Type
dose of Carbon Raw Purified Carbolex
(mg) lung lesion black Quartz CNTs CNTs CNTs
0.1 Inflammation 0 1 3 2 0
0.1 Granulomas 0 0 5 2 0
0.5 Inflammation 0 4 3 5 0
0.5 Granulomas 0 0 5 5 5b
aMice (5/group) were each instilled with 0.1 or 0.5 mg CNTs and
euthanized 90 days after the single treatment. Lungs were microscopi-
cally examined by a pathologist who had no knowledge of the treatment
of each animal. Table originally published in Lam et al. (2004).
bIncludes three mice that died in the first week.
lioid granulomas, fibrosis, and biochemical toxicity changes in
the lungs that might impair pulmonary functions. Carbon black
(ultrafine) or graphite, given to the animals in the same manner
by these research groups, produced no lung lesions. Cell culture
studies also showed that CNTs were cytotoxic. These results
indicate that, if CNT particulates reach the lung in sufficient
quantity, they will produce a toxic response.
2. Dose-Response and Exposure Duration-Response
Assessment
In the NASA study in which lungs of exposed mice were
examined 3months after instillation, granulomas were observed
in the high-dose group treated with a SWCNT product made
by Carbolex, but not in the low-dose group (Lam et al., 2004);
the Rice HiPco CNTs produced prominent granulomas in all
animals exposed to the high dose, while in the low-dose groups,
granulomas were less prominent or not detected (Table 2). A
more quantitative and morphometric study by Shvedova et al.
(2005) showed that the total mass of granulomas increased with
the increase of treatment doses (Figures 10A and 10B). The
effect of increased SWCNT dose in mice was assessed 60 days
after the treatment. The extent of fibrosis and the biomarkers
of toxicity in BALF were reported to be dose dependent, and
the lesions in mouse lungs became worse with time. Results for
MWCNTs reported by Muller et al. (2005) also showed a dose-
dependent increase in hydroxyproline and collagen contents in
the lungs of rats treated with the compound (Figures 10C and
10D); these two proteins are biomarkers for fibrosis. These data
strongly indicate that, if CNT particles reach the lung, the effects
will be dose dependent and time dependent.
3. Exposure Risk Assessment
Because CNTs tend to stick to each other, forming clumps,
it is difficult to separate substantial numbers of particles of res-
pirable size from bulk amounts of CNTs. Exposure risk will
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depend on the proportion of particles of respirable size that can
dissociate from the clumps. Particle deaggregation from unpro-
cessed HiPco and laser-ablated products was investigated by
aerosol scientists at NIOSH (Baron et al., 2003). They reported
that relatively gentle agitation in a two-component fluidized bed
did not lead to significant aerosol generation. More energetic
effort by blowing air over a CNT sample (from a laser prod-
uct) mixed with copper beads in a centrifuge tube, which had
been agitated with a vortex shaker, led to the generation of parti-
cles smaller than 100 nm. Vigorous agitation of a HiPco sample
produced more particles, most of which were in the respirable
range, with some being in the ultrafine range (Figure 5). Accord-
ing to these NIOSH scientists, “generation rates of fine particles
from the nanotube material were found to be approximately two
orders of magnitude below that for fumed alumina for similar
volumes of material.”
In a field study, when the NIOSH investigators sampled
airborne CNTs at the NASA JSC nanotechnology laboratory,
the Rice University nanotechnology research laboratory, and
the CNI manufacturing facility in 2002, the laboratories were
making only several grams of CNTs per day (Shvedova et al.,
2005). The researchers found very low concentrations (31 to
117 µg/m3) of HiPco or laser-produced CNT dust. Coarse and
nonrespirable particles contributed most of the mass. However,
because of their low density, nanotube particles were observed
to remain airborne for some time (duration not specified) (Baron
et al., 2003). The recovery of CNTs from synthetic ovens and
handling of the collected samples was gentle. Thus, losses of
this expensive material (>$500/g at that time) were minimized.
Warheit et al. (2004) used these NIOSH findings that very little
amounts of airborne CNT dust were found in these laboratories
and that majority of the particles were not in respirable range
to support their argument that airborne CNT dust is unlikely to
pose an exposure risk.
However, if Richard Smalley’s prediction that hundreds or
thousands of tons of nanotubes could be produced in 5 to 10
years and “in time, millions of tonnes of nanotubes will be pro-
duced worldwide every year” (Ball, 2001; Taubes, 2002) comes
true, and if the CNT industry achieves the goal of pricing CNTs
at “a couple dollars a pound” (Bearden, 2003), then some pro-
duction facilities with less stringent industrial hygiene practices
could have a much dustier environment than the laboratories
sampled by the NIOSH aerosol group. Moreover, CNT particles
in some products made by other manufacturers using different
synthetic processes may have lesser tendency to aggregate like
those investigated by the aerosol scientists (see Section I.B.4),
who visited the facilities using only the processes (HiPco and
laser ablation) that were developed by Smalley’s group at Rice
University. Further more, if CNTs are incorporated into rein-
forced structures, composite materials, and other products, air-
borne CNT dust found in manufacturing plants that make these
products may have different particle size distribution that ob-
served by Baron et al. A large work force will be exposed to
CNTs (see section I.B.5).
4. Risk Characterization
The animal toxicity studies discussed here were conducted
by ITI or modified processes, and all of the test materials were
prepared as fine-particle suspensions by ultrasonication in an
aqueous system with a dispersing agent or by boiling. These
instillation or aspiration studies used unnatural routes of admin-
istration; thus the studies were considered preliminary assays to
screen CNTs for potential pulmonary toxicity (Lam et al., 2004;
Warheit et al., 2004). Even though these studies do not answer
the important health risk question of whether airborne CNT par-
ticles can reach the lungs, they do reveal the intrinsic toxicity of
CNTs. All rat or mouse studies showed that CNTs, but not car-
bon black or graphite administered similarly, produced severe
lesions in the lungs. These findings convey an importantmessage
that, if a work environment contains respirable CNT particles in
significant concentration, prolonged exposures would likely re-
sult in serious lung diseases. Henderson et al. (1995) reported
that when the amount of particle deposition was comparable,
pulmonary responses to a bolus instillation and an inhalation
exposure were comparable. Therefore, it can be inferred that
differences between the animal results reported here and the re-
sults from future inhalation studies are likely to be quantitative,
but not qualitative. Certainly the risk assessment of CNTs needs
to be substantiated with animal inhalation studies.
The results of the toxicity studies conducted by NASA and
NIOSH demonstrate that, on an equal-weight basis and under
the test conditions described here, CNTs are more toxic than
quartz, which is considered a serious occupational health haz-
ard in chronic inhalation exposures. CNT products are much
lighter in weight than quartz, and a gram of CNT respirable
dust of comparable sizes would have many more fine parti-
cles than a gram of quartz dust. The Occupational Safety and
Health Administration (OSHA) current permissible exposure
limit (PEL) on quartz for occupational exposures is 0.1 mg/m3.
OSHA PELs are time-weighted concentrations (40 h/week)
and are set for lifetime occupational exposures. OSHA has
not established a PEL for CNTs. A major CNT manufacturer
and supplier classified this new form of carbon as synthetic
graphite; its material safety data sheet (Carbon Nanotechnolo-
gies Incorporated, 2002) references theOSHAPEL for synthetic
graphite of 5 mg/m3 for the respirable fraction (NIOSH/OSHA,
1988).
To estimate, from intratracheal doses that produced lung le-
sions, the risk associated with human inhalation exposure to a
dust, it is necessary to extrapolate from ITI to inhalation and
from animal to human. These processes are very complicated
and difficult (U.S. EPA, 2004), and the results may be ques-
tionable. Pulmonary deposition of a test dust depends on the
physiological condition and characteristics of the exposed ani-
mal/subject [respiratory tract anatomy, breathing patterns (oral-
nasal or nose-only, fast or slow, shallow or deep)] and on the
physical characteristics of the dust (density, morphology, geom-
etry, and particle distribution). The fractional deposition with
respect to the mass median aerodynamic diameter (MMAD) of
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the particles in various regions of the respiratory systemhas been
calculated and estimated mostly for humans. Aerodynamic di-
ameters are dependent on the physical characteristic of the par-
ticles. CNTs are very light and are aggregates of ropes, each
rope consisting of a bundle of parallel tubes. It would be more
difficult to determine the MMAD of CNTs than it would be to
determine the MMAD of common dusts studied by toxicolo-
gists. To perform an ITI route to inhalation route extrapolation
and to calculate the amount of dust deposition in an inhalation-
exposed animal, we previously assumed that 40% of the inhaled
respirable CNT particles were deposited in the pulmonary re-
gion (Lam et al., 2004). The 40% was derived from data of the
International Commission of Respiratory Protection TaskGroup
(Bates et al., 1966), which show that the fractional deposition
of particles deep in the human lung is about 30% for 3-µm par-
ticles and increases to 55% for 0.05-µm particles. These data
were gathered many years ago; they have been replaced with
recent data.
Recent data compiled by the U.S. EPA (2004) show the frac-
tional deposition of particles (density 1 g/cc) with an MMAD of
5.7µm in the tracheobronchiolar region and alveolar region of a
human are 2.4% and 5.5% respectively; the corresponding val-
ues for particles of 2 µm in a rat are 4% and 5.5%. Raabe et al.
(1988) reported that the alveolar deposition of 5-µm particles in
mice was 3%–4%. It appears that our previously assumed 40%
alveolar deposition was an overestimate (Lam et al., 2004), so
that a reassessment of exposure risk here is warranted.
CNTs are considered by some manufacturers to be synthetic
graphite; the MSDS from a major CNT supplier states the PEL
value of 5 mg/m3 set by OSHA for respirable synthetic graphite
dust (CNI, 2002). If we assume that a mouse is exposed to
5 mg/m3 of a respirable CNT dust and 4% of this dust will
be deposited in the alveolar region, this would allow us to es-
timate the length of time required for the animal to acquire a
lung burden equivalent to an ITI dose. CNT particles are neither
soluble nor biodegradable, and the instilled particles were found
predominately in the interstitium, where they could not be re-
moved from the lung by the macrophage-mucociliary clearance
mechanism and would remain in the lung for prolonged peri-
ods. Therefore, it is reasonable and for simplicity to assume no
dust clearance in the lung. If we also assume that a 30-g mouse
breathes in 30 ml (0.03 L or 0.00003 m3) of air per min or
0.0018 m3/h (Parent, 1992), then a mouse breathing respirable
CNT dust at 5 mg/m3 for 8 h for one day would accumulate
0.0029 mg CNT/day (5 mg/m3 × 4% × 0.0018 m3/h × 8 h =
0.00288 mg).
The above calculation shows that an amount of 0.0029 mg of
CNTswould be deposited in the lung if amousewere exposed for
8 hours to an airborne concentration of 5 mg/m3 of respirable
CNT dust. Using this CNT exposure concentration and daily
lung deposition of 0.0029 mg, it can be calculated that it will
take 179 daily 8-h exposures for a mouse to accumulate 0.5 mg
CNTs in its lungs (assuming no CNT elimination). In our study,
when 0.5 mg (the high dose) of CNTs was instilled into the
lung of a mouse, we observed severe lung lesions (Lam et al.,
2004). It is noteworthy that even the low dose of 0.1mg of HiPco
CNTs caused granulomas in 7 of the 10 treated mice (Table 2).
Henderson et al. (1995) reported that pulmonary responses to
an equal amount of dust deposited by an inhalation exposure or
by a bolus instillation were comparable. This calculation shows
that an animal breathing 5 mg/m3 for 179 days (8 h/d) would be
expected to have severe lung lesions. It is reasonable to assume
that if a person were to breathe respirable-size dust of CNTs at
this concentration and duration, his/her lungs would have some
lesions similar to those observed in the mice by Lam et al. Thus,
OSHA’s permissible exposure limit of 5mg/m3 set for respirable
synthetic graphite dust should not be recommended for CNTs.
This warning is consistent with the findings of Warheit et al.
(2004) showing that CNTs produced granulomas while graphite
(used as a negative control) elicited no toxicity in the lungs.
Toxicologically, CNTs are not equivalent to synthetic graphite.
Shvedova et al. (2005), using doses (0, 10, 20, or 40 µg/
mouse; about 0, 0.5, 1, or 2 mg/kg) that were about an order
of magnitude lower than those used by Lam et al. showed that
CNT toxicity in the lungs of treated mice is also dose-dependent
and progressive. Assuming a tidal volume of 500 ml and 18
breaths/min, they calculated the airway and alveolar deposition
efficiencies of particles (size 5 µm) in a human lung to be 8.3%
and 1.1% respectively. Using these data, Shvedova et al. further
calculated that the total lung deposition in a worker working 20
days (8 h/d) and breathing 5 mg/m3 CNTs of particle size 5 µm
would be about 40 mg. Of this amount, 4.7 mg would be in alve-
olar regions. The proximal alveolar deposition in the worker’s
lung after 20 days of CNT exposure would be 15.7 mg/m2; the
alveolar deposition in a mouse aspirating 20µg CNTs would be
16.6 mg/m2. The dose of 20 µg/mouse was shown to produce a
robust acute inflammation, rapid fibrogenic and granulomatous
reactions, and impaired pulmonary functions. Thus, a worker
exposed to 5 mg/m3 CNTs for 20 days could have lung lesions
similar to those of the CNT-treated mice.
To compare the risk estimations arrived at by two groups us-
ing different approaches, one could use Shvedova’s approach
with Lam’s assumption (4% alveolar deposition) and data. Lam
et al. instilled 0.5 mg/mouse (or 500µg/mouse), a dose that pro-
ducedmore severe lung lesions than those observed byShvedova
et al. Shvedova’s calculation shows that the dust mass per unit
alveolar surface area (mg/m2) of a mouse instilled with 20 µg
is approximately equal to that of a worker breathing 5 mg/m3
CNTs for 20 days. Using the same approach, one can calculate
that, if the instilled dose is 500µg, a worker would take 500 days
to achieve the same density of dust on his/her alveolar surface. If
Shvedova et al. had assumed a fractional alveolar deposition of
4% (as we assumed above in our recalculation with more recent
data) instead of 1.1%, they would have found that the worker
would take 136 days instead of 500 days to achieve the same
density of dust on the alveolar surface. Thus, using an instilled
dose of 0.5 mg and a deposition of 4%, Shvedova would calcu-
late a value of 136 days while Lam would calculate 170 days
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(see above). These numbers are considered close given that they
were obtained by different approaches. The difference may have
resulted from the assumption of 4% alveolar deposition for both
mice and humans; the 179 days were calculated for 4% deposi-
tion in mice and the 136 days were calculated for 4% deposition
in humans.
Both Lam et al. (2004) and Shvedova et al. (2005) showed
that an equal weight of CNTs was more toxic than quartz in
the lungs of treated mice. In a cell culture study with alveolar
macrophages, Jia et al. (2005) showed that both SWCNTs and
MWCNTs were more cytotoxic than quartz; CNTs, especially
SWCNTs, impaired phagocytosis and caused cell death. The
OSHA PEL for quartz is 0.1 mg/m3. Using the NIOSH group’s
approach and data, it can be estimated that a worker breath-
ing 0.1 mg/m3 would take 1000 days (∼3 years) to reach the
alveolar burden of 4.7 mg, also assuming no pulmonary elimi-
nation occurred; this exposure regimen is expected to produce
some lung lesions. Results of inhalation studies will be needed
to substantiate the pathological findings in animals and to set an
appropriate exposure limit. However, until such data are avail-
able, we recommend that the occupational exposure limit for
respirable CNT dust be set at a value no greater than 0.1 mg/m3.
G. Assessment of the Role of Environmental Multi-Wall
Carbon Nanotubes in Air Pollution-Related
Cardiopulmonary Diseases in the General Public
As discussed in the Introduction (sections I.C and I.D),
MWCNTs and fullerenes not only are produced by high-
technology laboratories but also are found in particulate matter
from ordinary combustion of fuel gases (Murr et al., 2004a).
“They’re also made in every candle flame and in forest fires,”
according to Richard Smalley (Amato, 2001; Wikipedia,
2005). Therefore, MWCNTs are probably ubiquitous in our
environment. MWCNTs generated outside laboratories or
factories would be expected to be shorter (Figure 6) than those
produced in the synthetic ovens (Figure 1B); because the van
der Waals force is less effective, they would also aggregate
with themselves and with other nanoparticles more loosely
than manufactured CNTs do (section I.D). In the lung, shorter
nanofibers and loose aggregates would favor dissociation of
MWCNTs from the inhaled and deposited aggregate matrix,
potentially allowing some of them to leave the lung and be
deposited in extrapulmonary organs. In a group of mice that
received SWCNTs by pharyngeal aspiration, Li et al. (2005), of
Shvedova’s group at NIOSH, observed dose-dependent damage
to the mitochondrial DNA in the aorta at 7, 28, and 60 days
after the CNT treatment. They concluded that these oxidative
changes were the result of altered expression of inflammatory
genes, including MCP-1 and VCAM-1, in the heart. Li et al.
(2006) further reported that the percent of plaque areas in
the aortas was significantly increased in the SWCNT-instilled
hypercholesterolemic mice compared with those instilled with
the vehicle. The CNT-treated mice showed a significant increase
of atherosclerotic lesions in the brachiocephalic arteries. The
authors speculated that these effects in the heart might be caused
by CNTs that leave the lung or by cytokines released from
inflammation areas in the lungs. If the toxicity of manufactured
and combustion-generated MWCNTs is similar to that of SW-
CNTs, one would expect that the looser aggregates of shorter
MWCNTs could have effects on the heart as well as the lung.
Fine particulate matter (PM 2.5) has been found to have
a strong association with cardiopulmonary diseases (Dockery
et al., 1993; Gauderman et al., 2004; Pope et al., 2002, 2004)
(section I.C.4). However, the underlying mechanisms of patho-
genesis of cardiopulmonary diseases associated with exposures
to fine particulate matter are not known (Pope, 2000). A few
mechanisms have been proposed including production of reac-
tive and oxidative species resulting in lung inflammation and
damage (Dreher, 2000; Pope et al., 1999), and release of po-
tentially harmful cytokines from fine particles induced alveolar
inflammation (Seaton et al., 1995).
Besides inducing histopathological changes, including gran-
uloma formation and fibrosis, both SWCNTs and MWCNTs
were found to release toxic cytokines and biomarkers of inflam-
mation, oxidative stress, and cytotoxicity (Muller et al., 2005;
Shvedova et al., 2005). As discussed above, Shvedova’s group
further found that SWCNTs produced functional respiratory de-
ficiency, decreased bacterial clearance, and biochemical toxicity
in the heart in treated mice. It is true that inorganic, metallic and
organic constituents in the PM could contribute to the pathogen-
esis of lung diseases (Dreher, 2000). The fact that inorganic car-
bon, which includes MWCNTs, accounts for a significant frac-
tion in the combustion-generatedPM, and thefindings thatCNTs
were rather toxic and capable of producing so many lung lesions
and chemical and cellular changes commonly associated with
air pollutants, makeMWCNT particulates a prime suspect in the
pathogenesis of cardiopulmonary diseases induced by fine PM.
IV. CONCLUSIONS AND RECOMMENDATIONS
A. Manufactured Carbon Nanotubes
The animal studies of CNT pulmonary toxicity show that
CNTs are capable of inducing inflammation, epithelioid gran-
ulomas, fibrosis, and biochemical toxicity changes in the lungs
that might impair pulmonary functions. However, the studies
reviewed here were conducted using ITI or modified techniques
to administer to rodents CNT suspensions that had been me-
chanically ultrasonicated. Even though ITI and modifications
of this technique are common routes of administration used to
assess the toxicity of dust in the lungs, it is imperative that in-
halation toxicity studies be conducted to demonstrate whether
CNT particles can reach the lung to produce the lung lesions
seen in the ITI studies. Results from inhalation exposure stud-
ies would also allow assessment of the effects of CNTs on the
upper respiratory tract and establishment of an exposure limit.
With respect to occupational exposure limits and exposure haz-
ard, CNTs should not be treated as synthetic graphite. Unless
and until unequivocal data from inhalation studies can show
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that CNTs are devoid of toxicity, it is prudent to presume that
prolonged occupational exposure to airborne fine CNT particu-
late matter could produce serious lesions in the lungs similar to
those seen in animals. Therefore, if airborne fine CNT particles
are present in the workplace, strategies to minimize human ex-
posures must be implemented, as recommended by Lam et al.
(2004).
B. Multiwall Carbon Nanotubes Generated
by Fuel Combustion
Fine environmental particulate matter (PM 2.5) has been
found to have a strong association with cardiopulmonary dis-
eases (Dockery et al., 1993; Gauderman et al., 2004; Pope et al.,
2002, 2004), andMWCNTswere found in significant amounts in
fine particulate matter in environmental samples collected in El
Paso andHouston (Murr et al., 2004b). The results of pulmonary
toxicity studies discussed here showed that manufactured SW-
CNTs and MWCNTs caused histopathological changes in ro-
dent lungs, including granuloma formation and fibrosis; both
were found to release toxic cytokines and biomarkers of inflam-
mation, oxidative stress, and cytotoxicity (Muller et al., 2005;
Shvedova et al., 2005). In addition to producing pulmonary le-
sions, SWCNTs were shown to produce cardiac toxicity (Li
et al., 2005, 2006). These findings suggest that MWCNT partic-
ulates may be involved in the pathogenesis of fine PM-induced
cardiopulmonary diseases. For this to be substantiated, however,
a direct link between pollution-associated cardiopulmonary dis-
eases and environmental MWCNTs would need to be estab-
lished. The fine PM2.5 samples collected byDockery and Pope’s
group (Dockery et al., 1993;Gauderman et al., 2004; Pope et al.,
2002; Pope et al., 2004) or by others in environmental studies
should be analyzed for their content of MWCNTs. Gauderman
et al. (2004) showed that impairment of lung functions resulted
from air pollutants that had the highest correlation between
pathological effects and amounts of elemental carbon. Did this
environmental elemental carbon contain substantial amounts of
MWCNTs, a newly identified carbon allotrope? The discovery
of CNTs not only has triggered an enormous amount of research
on applications of these manufactured novel materials; it soon
will trigger a vast amount of research on the effects of these
long-existing, combustion-generated environmental pollutants
on human health.
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